Joy Y Feng
11PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.David R Martinez, Fernando R Moreira, Nicholas J Catanzaro
|Feb 01, 2023
Structural basis for substrate selection by the SARS-CoV-2 replicase.Brandon F Malone, Jason K Perry, Paul Dominic B Olinares
|Dec 22, 2022
Interfering with nucleotide excision by the coronavirus 3'-to-5' exoribonuclease.Rukesh Chinthapatla, Mohamad Sotoudegan, Pankaj Srivastava
|Jul 09, 2022
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2.Joy Y Feng, Venice Du Pont, Darius Babusis
|Mar 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.Alexandra Schäfer, David R Martinez, John J Won
|Aug 09, 2021
Reply to Yan and Muller, "Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver".Eisuke Murakami, John Bilello, Ruidong Li
Pageof 2
Frequent Collaborators
3 joint publications
John P Bilello
3 joint publications
Timothy P Sheahan
3 joint publications
Jason K Perry
3 joint publications
Roy Bannister
3 joint publications
Darius Babusis
3 joint publications
Ralph S Baric
2 joint publications
Stephanie Dong
2 joint publications
Kimberly T Barrett
2 joint publications
Alexandra Schäfer
2 joint publications
Richard L Mackman
